| Trial ID: | L6050 |
| Source ID: | NCT04255238
|
| Associated Drug: |
Gemigliptin 50mg
|
| Title: |
A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Gemigliptin 50mg|DRUG: Dapagliflozin 10mg
|
| Outcome Measures: |
Primary: Chages from baseline HbA1c at Week24, Baseline to Week24 |
|
| Sponsor/Collaborators: |
Sponsor: LG Chem
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
468
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2020-06-30
|
| Completion Date: |
2022-12-30
|
| Results First Posted: |
|
| Last Update Posted: |
2020-02-19
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT04255238
|
